RCM
TDOC icon

Radcliffe Capital Management’s Teladoc Health TDOC Stock Holding History

Radcliffe Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$269K Sell
31,700
-169,600
-84% -$1.13M 0.02% 265
2026
Q1 		$1.1M Hold
201,300
– – 0.08% 223
2025
Q4 		$1.41M Sell
201,300
-61,100
-23% -$478K 0.08% 185
2025
Q3 		$2.03M Buy
262,400
+235,000
+858% +$1.83M 0.13% 131
2025
Q2 		$239K Buy
+27,400
New +$199K 0.02% 121

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Radcliffe Capital Management's TDOC Position: Q2 2026 in Review

Radcliffe Capital Management reduced its Teladoc Health (TDOC) stake by 84% in Q2 2026, selling an estimated $1.13M and leaving 31,700 shares worth $269K. The position accounts for 0.02% of the portfolio, ranked #265.

Radcliffe Capital Management first reported a position in TDOC in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.03M in Q3 2025. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Radcliffe Capital Management held 31,700 shares of Teladoc Health worth $269K as of Q2 2026.
  • Radcliffe Capital Management sold 169,600 Teladoc Health shares in Q2 2026, an estimated $1.13M.
  • Teladoc Health made up 0.02% of Radcliffe Capital Management's portfolio in Q2 2026, its #265 holding.
  • Radcliffe Capital Management first reported a position in Teladoc Health in Q2 2025 and has held it in 5 quarters since.
  • Radcliffe Capital Management's Teladoc Health position peaked at $2.03M in Q3 2025.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Radcliffe Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.